As the United Kingdom's FTSE 100 index faces downward pressure due to weak trade data from China and global market uncertainties, investors are keenly observing potential opportunities amidst these challenges. In such a fluctuating environment, identifying stocks that may be trading below their estimated value can offer a strategic advantage, as they might provide long-term growth potential when broader market conditions stabilize. Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom Name Current Price Fair Value (Est) Discount (Est) Victorian Plumbing Group (AIM:VIC) £0.704 £1.18 40.2% TBC Bank Group (LSE:TBCG) £48.20 £95.53 49.5% On the Beach Group (LSE:OTB) £2.58 £4.19 38.4% NIOX Group (AIM:NIOX) £0.71 £1.10 35.3% Moonpig Group (LSE:MOON) £2.11 £3.99 47.1% Man Group (LSE:EMG) £1.664 £3.30 49.5% Kromek Group (AIM:KMK) £0.052 £0.089 41.9% Deliveroo (LSE:ROO) £1.772 £3.07 42.2% Coats Group (LSE:COA) £0.733 £1.14 35.5% Advanced Medical Solutions Group (AIM:AMS) £2.01 £3.51 42.7% Click here to see the full list of 23 stocks from our Undervalued UK Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Applied Nutrition Overview: Applied Nutrition Plc manufactures, wholesales, and retails sports nutritional products in the United Kingdom and internationally, with a market cap of £329.50 million. Operations: The company generates revenue primarily from its Vitamins & Nutrition Products segment, totaling £88.35 million. Estimated Discount To Fair Value: 33.5% Applied Nutrition is trading at £1.32, significantly below its estimated fair value of £1.98, suggesting undervaluation based on discounted cash flow analysis. Its earnings are forecast to grow 15.72% annually, outpacing the UK market's growth rate of 13.2%. Recent board appointments include Peter Cowgill and Deepti Velury Bakhshi, adding strategic leadership expertise that could support future growth initiatives and operational efficiencies in line with its revenue projections exceeding the UK market average. Insights from our recent growth report point to a promising forecast for Applied Nutrition's business outlook. Navigate through the intricacies of Applied Nutrition with our comprehensive financial health report here.LSE:APN Discounted Cash Flow as at Aug 2025 Man Group Overview: Man Group Limited is a publicly owned investment manager with a market cap of approximately £1.88 billion. Operations: The company generates revenue primarily from its Investment Management Business, which amounts to $1.31 billion. Estimated Discount To Fair Value: 49.5% Man Group is trading at £1.66, significantly below its estimated fair value of £3.3, highlighting undervaluation based on discounted cash flow analysis. Earnings are forecast to grow 32.8% annually, surpassing the UK market's growth rate of 13.3%. Despite a recent decline in revenue and net income for H1 2025 compared to the previous year, strategic moves like potential acquisitions could enhance future profitability and leverage opportunities within the private credit market. Story Continues According our earnings growth report, there's an indication that Man Group might be ready to expand. Click here to discover the nuances of Man Group with our detailed financial health report.LSE:EMG Discounted Cash Flow as at Aug 2025 Just Group Overview: Just Group plc offers retirement income products and services to individuals, homeowners, and corporate clients in the United Kingdom, with a market cap of £2.18 billion. Operations: Revenue segments for the company include various retirement income products and services targeted at individuals, homeowners, and corporate clients within the UK market. Estimated Discount To Fair Value: 27.6% Just Group is trading at £2.1, below its estimated fair value of £2.9, indicating undervaluation based on cash flows. Earnings and revenue are projected to grow significantly faster than the UK market over the next few years, though recent profit margins have decreased from 6.3% to 3.2%. The acquisition by Brookfield Wealth Solutions for £2.3 billion may impact future valuations and strategic direction, pending regulatory approvals by mid-2026. Our earnings growth report unveils the potential for significant increases in Just Group's future results. Unlock comprehensive insights into our analysis of Just Group stock in this financial health report.LSE:JUST Discounted Cash Flow as at Aug 2025 Where To Now? Explore the 23 names from our Undervalued UK Stocks Based On Cash Flows screener here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:APN LSE:EMG and LSE:JUST. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
UK Stocks That May Be Trading Below Their Estimated Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...